XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues $ 108,435 $ 87,125
Cost of revenues 94,943 69,671
Gross profit 13,492 17,454
Operating expenses:    
Research and development 10,470 11,015
Selling, general and administrative 27,494 25,322
Amortization of acquisition related intangibles 2,467 1,222
Change in fair value of contingent consideration (5,850) 3,060
Total operating expenses 34,581 40,619
Operating loss (21,089) (23,165)
Interest income, net 75 426
Other expense, net (28) (771)
Loss before income tax expense (21,042) (23,510)
Income tax benefit (1,849) (832)
Net loss $ (19,193) $ (22,678)
Net loss per common share    
Basic (in dollars per share) $ (0.71) $ (0.95)
Diluted (in dollars per share) $ (0.71) $ (0.95)
Weighted average number of common shares outstanding    
Basic (in shares) 27,203,000 23,879,000
Diluted (in shares) 27,203,000 23,879,000